Singapore- Bluebird Bio and Gritstone Oncology collaborates to research, develop and commercialize products for the trea...
Royal Philips, a global leader in health technology, has introduced the EPIQ CVx cardiovascular ultrasound system. Built...
Edmonton's General Intermediates of Canada Inc. (GIC) has received conditional funding from the National Research Counci...
Singapore - Achillion Pharmaceuticals appoints Steven Zelenkofske, D.O. to the position of Executive Vice President...
In a new study, researchers developed a gene expression predictor that can indicate whether melanoma in a specific patie...
Singapore - ASLAN Pharmaceuticals, a clinical-stage biopharmaceutical company targeting cancers that are both highly pre...
Tolero Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for hematologi...
Verana Health, the developer of a cutting-edge platform for life science innovation that utilizes regulatory-grade speci...
The U.S. Food and Drug Administration has approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-...
An interdisciplinary group of scientists from NUST MISIS, Lomonosov Moscow State University, Pirogov Russian National Re...
University of Birmingham women’s cancer expert Dr Sudha Sundar has been chosen as the President-Elect of the Briti...
rfxcel, the global leader in track and trace solutions, releases enhancements to its compliance solution for Russia and ...
The Buck Institute, Juvenescence, and Insilico Medicine have announced a research collaboration utilizing artificial int...
Global pharmaceutical company Mylan N.V. has announced the U.S. launch of Tadalafil Tablets USP, 20 mg, the f...
Orchard Therapeutics, a leading commercial-stage company dedicated to transforming the lives of patients with rare disea...
MIT researchers, including one of Indian-origin, have developed novel machine-learning techniques to improve the quality...
Singapore – The U.S. Food and Drug Administration recently approved Galafold (migalastat), the first oral medicati...
Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company developing innovative treatments for cancer ...
